A PCR-mutagenesis strategy for rapid detection of mutations in codon 634 of the ret proto-oncogene related to MEN 2A

BMC Medical Genetics

Volumn 3, Issue , 2002, Pages

  Roqué, María ^a   Pusiol, Eduardo ^a   Perinetti, Héctor ^b   Godoy, Clara Pott ^a   Mayorga, Luis S ^a  

^a UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DNA; ETHIDIUM BROMIDE; PROTEIN RET; RESTRICTION ENDONUCLEASE;

ARTICLE; CODON; DNA DETERMINATION; DOMINANT INHERITANCE; FAMILY HISTORY; GENE AMPLIFICATION; GENETIC CODE; GENETIC SCREENING; HUMAN; HUMAN CELL; INCUBATION TIME; MISSENSE MUTATION; MULTIGENE FAMILY; MUTAGENESIS; MUTATIONAL ANALYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTO ONCOGENE; SIPPLE SYNDROME; THYROID CARCINOMA; ULTRAVIOLET RADIATION;

EID: 0242524316     PISSN: 14712350     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2350-3-4     Document Type: Article

References (12)

1. Sanchez B: High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain. J Med Genet 1999, 36:68-70
2. Nakamura T, Ishizaka Y, Nagao M, Hara M, Ishikawa T: Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin. J Pathol. 1994, 172(3):255-260
3. Durbec P, Marcos Gutierrez CV, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Constantini F, Saarma M, et al: GDNF signaling through the Ret receptor tyrosine kinase. Nature 1996, 381:789-793
4. Mehlen P, Bredesen DE: Dependence receptors:links between apoptosis, nervous system development and control of tumorigenesis. Bull Cancer 2000, 87(7-8):537-541
5. Bordeaux MC, Forcet C, Granger L, Corset V, Bidaud C, Bredesen DE, Edery P, Mehlen P, Bidaud M: The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO 2000, 19(15):4056-4063
6. Bongarzone I: The Glu632-Leu633 deletion in cysteine rich domain of Ret induces constitutive dimerization and alters the processing of the receptor protein. Oncogene 1999, 18(34):4833-4838
7. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MN, et al: Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science. 1995, 267(5196):381-383
8. Asai N, Iwashita T, Matsuyana M, Takahaski M: Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasias 2A mutations. Mol Cell Biol. 1995, 15(3):1613-1619
9. Huang SC, Koch CA, Vortmeyer AO, Pack SD, Lichtenauer UD, Mannan P, Lubensky IA, Chrousos PG, Gagel RF, Pacak K, Zhuang Z: Duplication of the mutant RET allele in trisomy 10 or loss of the wild type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas. Cancer Res 2000, 60(22):6223-6226
10. Roqué M, Pusiol E, Perinetti H, Mayorga LS: Diagnóstico de MEN IIA mediante la detección de mutaciones puntuales en el protooncogen RET. Endocrinología 1997, 44:291-295
11. Miller SA: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1998, 16:1215-1220
12. Jhiang SM: The RET proto-oncogene in human cancers. Oncogene 2000, 19(49):5590-7